Do analysts rate LFMD or RYOJ?

LifeMD currently has a consensus price target of $7.57, suggesting a potential upside of 135.14%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, LFMD or RYOJ?

LifeMD has higher revenue and earnings than RYOJ. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $194.05M 0.80 $14.35M -$0.05 N/A RYOJ $9.34M 4.50 $120K N/A N/A

Is LFMD or RYOJ more profitable?

LifeMD has a net margin of 0.10% compared to RYOJ's net margin of 0.00%. RYOJ's return on equity of 0.00% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 0.10% -168.23% -31.27% RYOJ N/A N/A N/A

Do analysts recommend RYOJ or JYNT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Joint 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Which has stronger valuation & earnings, RYOJ or JYNT?

Joint has higher revenue and earnings than RYOJ. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RYOJ $9.34M 4.50 $120K N/A N/A Joint $54.90M 2.17 $2.91M $0.27 31.26

Is RYOJ or JYNT more profitable?

Joint has a net margin of 6.49% compared to RYOJ's net margin of 0.00%. Joint's return on equity of 12.02% beat RYOJ's return on equity. Company Net Margins Return on Equity Return on Assets RYOJ N/A N/A N/A Joint 6.49% 12.02% 3.47%

Do analysts rate RYOJ or PARK?

Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 40.12%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts plainly believe Park Dental Partners is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Park Dental Partners 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has higher earnings and valuation, RYOJ or PARK?

RYOJ has higher earnings, but lower revenue than Park Dental Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RYOJ $9.34M 4.50 $120K N/A N/A Park Dental Partners $244.49M 0.40 -$360K $1.05 19.37

Is RYOJ or PARK more profitable?

Company Net Margins Return on Equity Return on Assets RYOJ N/A N/A N/A Park Dental Partners N/A N/A N/A

Do analysts rate RYOJ or ACH?

Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 61.19%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Which has stronger earnings and valuation, RYOJ or ACH?

RYOJ has higher earnings, but lower revenue than Accendra Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RYOJ $9.34M 4.50 $120K N/A N/A Accendra Health $2.73B 0.03 -$1.10B -$3.91 N/A

Do analysts recommend PIII or RYOJ?

P3 Health Partners currently has a consensus price target of $17.00, suggesting a potential upside of 121.64%. Given P3 Health Partners' stronger consensus rating and higher possible upside, equities research analysts plainly believe P3 Health Partners is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, PIII or RYOJ?

RYOJ has lower revenue, but higher earnings than P3 Health Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio P3 Health Partners $1.46B 0.04 -$147.95M -$33.00 N/A RYOJ $9.34M 4.50 $120K N/A N/A

Is PIII or RYOJ more profitable?

RYOJ has a net margin of 0.00% compared to P3 Health Partners' net margin of -6.55%. Company Net Margins Return on Equity Return on Assets P3 Health Partners -6.55% N/A -16.40% RYOJ N/A N/A N/A

RYOJ (RYOJ) Competitors

$3.64 -0.08 (-2.15%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$3.71 +0.07 (+1.92%)

As of 09/18/2026 07:30 PM Eastern

Compare

RYOJ vs. LFMD, JYNT, PARK, ACH, and PIII

Should you buy RYOJ stock or one of its competitors? RYOJ's main competitors and comparable companies include LifeMD (LFMD), Joint (JYNT), Park Dental Partners (PARK), Accendra Health (ACH), and P3 Health Partners (PIII). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does RYOJ compare to LifeMD?

LifeMD (NASDAQ:LFMD) and RYOJ (NASDAQ:RYOJ) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

LifeMD has a net margin of 0.10% compared to RYOJ's net margin of 0.00%. RYOJ's return on equity of 0.00% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	0.10%	-168.23%	-31.27%
RYOJ	N/A	N/A	N/A

LifeMD currently has a consensus price target of $7.57, suggesting a potential upside of 135.14%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, LifeMD had 5 more articles in the media than RYOJ. MarketBeat recorded 5 mentions for LifeMD and 0 mentions for RYOJ. LifeMD's average media sentiment score of 0.36 beat RYOJ's score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company	Overall Sentiment
LifeMD	Neutral
RYOJ	Neutral

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

LifeMD has higher revenue and earnings than RYOJ.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	0.80	$14.35M	-$0.05	N/A
RYOJ	$9.34M	4.50	$120K	N/A	N/A

Summary

LifeMD beats RYOJ on 10 of the 13 factors compared between the two stocks.

How does RYOJ compare to Joint?

RYOJ (NASDAQ:RYOJ) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.

Joint has a net margin of 6.49% compared to RYOJ's net margin of 0.00%. Joint's return on equity of 12.02% beat RYOJ's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RYOJ	N/A	N/A	N/A
Joint	6.49%	12.02%	3.47%

Joint has higher revenue and earnings than RYOJ.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYOJ	$9.34M	4.50	$120K	N/A	N/A
Joint	$54.90M	2.17	$2.91M	$0.27	31.26

In the previous week, RYOJ's average media sentiment score of 0.00 equaled Joint'saverage media sentiment score.

Company	Overall Sentiment
RYOJ	Neutral
Joint	Neutral

76.9% of Joint shares are owned by institutional investors. 30.2% of Joint shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Joint	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Joint beats RYOJ on 8 of the 9 factors compared between the two stocks.

How does RYOJ compare to Park Dental Partners?

RYOJ (NASDAQ:RYOJ) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

RYOJ has higher earnings, but lower revenue than Park Dental Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYOJ	$9.34M	4.50	$120K	N/A	N/A
Park Dental Partners	$244.49M	0.40	-$360K	$1.05	19.37

Company	Net Margins	Return on Equity	Return on Assets
RYOJ	N/A	N/A	N/A
Park Dental Partners	N/A	N/A	N/A

Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 40.12%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts plainly believe Park Dental Partners is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, RYOJ's average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company	Overall Sentiment
RYOJ	Neutral
Park Dental Partners	Neutral

Summary

Park Dental Partners beats RYOJ on 5 of the 7 factors compared between the two stocks.

How does RYOJ compare to Accendra Health?

RYOJ (NASDAQ:RYOJ) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 61.19%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

RYOJ has higher earnings, but lower revenue than Accendra Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYOJ	$9.34M	4.50	$120K	N/A	N/A
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A

RYOJ has a net margin of 0.00% compared to Accendra Health's net margin of -11.41%. RYOJ's return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RYOJ	N/A	N/A	N/A
Accendra Health	-11.41%	-4.02%	0.70%

In the previous week, Accendra Health had 3 more articles in the media than RYOJ. MarketBeat recorded 3 mentions for Accendra Health and 0 mentions for RYOJ. Accendra Health's average media sentiment score of 0.50 beat RYOJ's score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Overall Sentiment
RYOJ	Neutral
Accendra Health	Positive

Summary

Accendra Health beats RYOJ on 6 of the 10 factors compared between the two stocks.

How does RYOJ compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and RYOJ (NASDAQ:RYOJ) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

P3 Health Partners currently has a consensus price target of $17.00, suggesting a potential upside of 121.64%. Given P3 Health Partners' stronger consensus rating and higher possible upside, equities research analysts plainly believe P3 Health Partners is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, P3 Health Partners' average media sentiment score of 0.00 equaled RYOJ'saverage media sentiment score.

Company	Overall Sentiment
P3 Health Partners	Neutral
RYOJ	Neutral

RYOJ has lower revenue, but higher earnings than P3 Health Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.04	-$147.95M	-$33.00	N/A
RYOJ	$9.34M	4.50	$120K	N/A	N/A

RYOJ has a net margin of 0.00% compared to P3 Health Partners' net margin of -6.55%.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-6.55%	N/A	-16.40%
RYOJ	N/A	N/A	N/A

7.8% of P3 Health Partners shares are owned by institutional investors. 10.9% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

P3 Health Partners beats RYOJ on 6 of the 10 factors compared between the two stocks.

Get RYOJ News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYOJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RYOJ vs. The Competition

Export

Metric	RYOJ	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$43.02M	$9.80B	$7.24B	$13.14B
Dividend Yield	N/A	2.61%	2.57%	12.30%
P/E Ratio	N/A	34.09	275.79	25.40
Price / Sales	4.50	4.98	695.58	114.44
Price / Cash	72.25	123.23	77.42	51.66
Price / Book	6.74	5.30	10.46	6.33
Net Income	$120K	$313.45M	$3.49B	$358.33M
7 Day Performance	-21.72%	1.65%	0.59%	1.12%
1 Month Performance	-21.21%	-0.98%	-2.01%	-2.67%
1 Year Performance	N/A	15.82%	18.09%	6.01%

RYOJ Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RYOJ RYOJ	N/A	$3.64 -2.2%	N/A	N/A	$43.02M	$9.34M	N/A	N/A
LFMD LifeMD	2.6019 of 5 stars	$3.22 +0.6%	$7.57 +135.1%	-49.9%	$154.24M	$194.05M	N/A	384	News Coverage Analyst Forecast
JYNT Joint	2.3267 of 5 stars	$8.44 +0.1%	N/A	-17.7%	$119.23M	$54.90M	31.26	330	Positive News Analyst Downgrade High Trading Volume
PARK Park Dental Partners	4.0351 of 5 stars	$20.34 +0.3%	$28.50 +40.1%	N/A	$96.44M	$244.49M	N/A	1,212	Positive News High Trading Volume
ACH Accendra Health	1.9137 of 5 stars	$0.93 -9.7%	$1.50 +61.2%	N/A	$79.21M	$2.73B	4.48	6,500	News Coverage Positive News Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RYOJ) was last updated on 9/19/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RYOJ (RYOJ) Competitors

RYOJ vs. LFMD, JYNT, PARK, ACH, and PIII

How does RYOJ compare to LifeMD?

Summary

How does RYOJ compare to Joint?

Summary

How does RYOJ compare to Park Dental Partners?

Summary

How does RYOJ compare to Accendra Health?

Summary

How does RYOJ compare to P3 Health Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RYOJ vs. The Competition

RYOJ Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RYOJ (RYOJ) Competitors

RYOJ vs. LFMD, JYNT, PARK, ACH, and PIII

How does RYOJ compare to LifeMD?

Is LFMD or RYOJ more profitable?

Do analysts rate LFMD or RYOJ?

Does the media prefer LFMD or RYOJ?

Do insiders & institutionals hold more shares of LFMD or RYOJ?

Which has preferable valuation & earnings, LFMD or RYOJ?

Summary

How does RYOJ compare to Joint?

Is RYOJ or JYNT more profitable?

Which has stronger valuation & earnings, RYOJ or JYNT?

Does the media refer more to RYOJ or JYNT?

Do insiders & institutionals believe in RYOJ or JYNT?

Do analysts recommend RYOJ or JYNT?

Summary

How does RYOJ compare to Park Dental Partners?

Which has higher earnings and valuation, RYOJ or PARK?

Is RYOJ or PARK more profitable?

Do analysts rate RYOJ or PARK?

Does the media refer more to RYOJ or PARK?

Summary

How does RYOJ compare to Accendra Health?

Do analysts rate RYOJ or ACH?

Which has stronger earnings and valuation, RYOJ or ACH?

Is RYOJ or ACH more profitable?

Does the media prefer RYOJ or ACH?

Summary

How does RYOJ compare to P3 Health Partners?

Do analysts recommend PIII or RYOJ?

Does the media prefer PIII or RYOJ?

Which has stronger earnings and valuation, PIII or RYOJ?

Is PIII or RYOJ more profitable?

Do institutionals and insiders have more ownership in PIII or RYOJ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RYOJ vs. The Competition

RYOJ Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools